| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.0052 | 1 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00069 | 1 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.00071 | 1 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.00069 | 1 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.00052 | 1 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.00031 | 1 |